AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in QuebecGlobeNewsWire • 11/25/25
The Zacks Analyst Blog JPMorgan, Netflix, AbbVie and Ohio Valley BancZacks Investment Research • 11/24/25
AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular LymphomaPRNewsWire • 11/18/25
Here's How Neuroscience Drugs Aided AbbVie's Top-line Growth in Q3Zacks Investment Research • 11/18/25
Here Are Thursday's Top Wall Street Analyst Research Calls: AbbVie, AppLovin, Autozone, Booking Holdings, CoreWeave, DoorDash, and More24/7 Wall Street • 11/13/25
Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage DisordersGlobeNewsWire • 11/12/25
Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio ExcellencePRNewsWire • 11/12/25
What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill.The Motley Fool • 11/09/25